Literature DB >> 29139552

Critical evaluation of the PALM-COEIN classification system among women with abnormal uterine bleeding in low-resource settings.

Divya Shubham1, Anjali S Kawthalkar1.   

Abstract

OBJECTIVE: To assess the feasibility of the PALM-COEIN system for the classification of abnormal uterine bleeding (AUB) in low-resource settings and to suggest modifications.
METHODS: A prospective study was conducted among women with AUB who were admitted to the gynecology ward of a tertiary care hospital and research center in central India between November 2014 and October 2016. All patients were managed as per department protocols. The causes of AUB were classified before treatment using the PALM-COEIN system (classification I) and on the basis of the histopathology reports of the hysterectomy specimens (classification II); the results were compared using classification II as the gold standard.
RESULTS: The study included 200 women with AUB; hysterectomy was performed in 174 women. Preoperative classification of AUB per the PALM-COEIN system was correct in 130 (65.0%) women. Adenomyosis (evaluated by transvaginal ultrasonography) and endometrial hyperplasia (evaluated by endometrial curettage) were underdiagnosed.
CONCLUSION: The PALM-COEIN classification system helps in deciding the best treatment modality for women with AUB on a case-by-case basis. The incorporation of suggested modifications will further strengthen its utility as a pretreatment classification system in low-resource settings.
© 2017 International Federation of Gynecology and Obstetrics.

Entities:  

Keywords:  Abnormal uterine bleeding; Low-resource settings; PALM-COEIN classification system

Mesh:

Year:  2017        PMID: 29139552     DOI: 10.1002/ijgo.12388

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  1 in total

1.  Clinical bleeding patterns and management techniques of abnormal uterine bleeding at a teaching and referral hospital in Western Kenya.

Authors:  Godfrey Shichenje Mutakha; Emily Mwaliko; Philip Kirwa
Journal:  PLoS One       Date:  2020-12-02       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.